Weekly Intelligence · 3 articles
Vet Industry Intel: Apr 12 – Apr 18, 2026
High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.
Regulatory & Policy (2)
Products & Technology (1)
Regulatory & Policy
Apr 15, 2026 [8/10] fda_cvm
Ready-to-use feline OA stem cell therapy gains entry to FDA’s faster conditional approval pathway - DVM360
A ready-to-use feline osteoarthritis stem cell therapy has been accepted into the FDA's conditional approval pathway.
FDA · DVM360
Apr 17, 2026 [7/10] fda_cvm
Four animal drugs cleared to fight New World screwworm - AGDAILY
The FDA cleared four animal drugs to combat the New World screwworm.
FDA · AGDAILY
Products & Technology
Apr 15, 2026 [7/10] fda_cvm
Gallant Reports Positive Pilot Data for Feline Osteoarthritis Stem Cell Therapy; Receives FDA Eligibility for Expanded Conditional Approval Pathway - PR Newswire
Gallant announced positive pilot data for its feline osteoarthritis stem cell therapy and received FDA eligibility for an expanded conditional approval pathway.
Gallant · FDA · PR Newswire